Deepa Pandey, a Healthcare Industry Expert, highlights that the Europe recombinant protein manufacturing services market has reached USD 1,896.21 million in 2026 and is on track to reach USD 6,117.86 million by 2035, advancing at a CAGR of 13.90%. Key Europe recombinant protein manufacturing services market companies shaping the market include Lonza Group AG, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim BioXcellence, Thermo Fisher Scientific (Patheon Biologics), while major growth segments span service type, host cell, molecule type, end user.